hat
Cetilistat te konplete Faz 1 ak 2 esè nan Lwès la e li aktyèlman nan tras faz 3 nan Japon kote li patenarya avèk Takeda. Norgina BV gen kounye a akeri tout dwa mondyal yo nan cetilistat soti nan Alizyme apre lèt la antre nan administrasyon an.
eng
Cetilistat has completed Phase 1 and 2 trials in the West and is currently in Phase 3 trials in Japan where it is partnered with Takeda. Norgina BV has now acquired the full global rights to cetilistat from Alizyme after the latter went into administration.